SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009669
Filing Date
2022-05-12
Accepted
2022-05-12 16:12:29
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eq-20220331.htm   iXBRL 10-Q 2292805
2 EX-31.1 eq-ex31_1.htm EX-31.1 13773
3 EX-31.2 eq-ex31_2.htm EX-31.2 13931
4 EX-32.1 eq-ex32_1.htm EX-32.1 12380
  Complete submission text file 0000950170-22-009669.txt   7865188

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eq-20220331_cal.xml EX-101.CAL 55189
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eq-20220331_pre.xml EX-101.PRE 305345
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eq-20220331.xsd EX-101.SCH 47283
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eq-20220331_def.xml EX-101.DEF 192369
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eq-20220331_lab.xml EX-101.LAB 421483
55 EXTRACTED XBRL INSTANCE DOCUMENT eq-20220331_htm.xml XML 1385437
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 22917934
SIC: 2834 Pharmaceutical Preparations